New radiation technique aims to zap prostate tumors with fewer side effects

NCT ID NCT07468903

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial tests a type of internal radiation called high-dose-rate brachytherapy for men with early-stage prostate cancer. The goal is to see if focusing radiation only on the tumor can control the cancer while causing fewer urinary and sexual problems than standard treatments. About 45 men will take part, and researchers will track side effects and how well the cancer is controlled.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
high-dose-rate brachytherapy (internal radiation therapy)
What this could lead to
If successful, this approach could offer a way to control prostate cancer with fewer urinary and sexual side effects than standard treatments.
What could go wrong
This is a small, early-phase trial with only 45 participants, so results may not apply to all patients. There is still a risk of side effects or the cancer not being fully controlled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCLA / Jonsson Comprehensive Cancer Center

    RECRUITING

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.